BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 8371702)

  • 1. Steady but slow progress toward AIDS vaccine.
    Minn Med; 1993 Aug; 76(8):38-9. PubMed ID: 8371702
    [No Abstract]   [Full Text] [Related]  

  • 2. AIDS vaccine development.
    Lévy JP
    Science; 1998 May; 280(5365):806-7. PubMed ID: 9599149
    [No Abstract]   [Full Text] [Related]  

  • 3. Disappointing data scuttle plans for large-scale AIDS vaccine trial.
    Cohen J
    Science; 2002 Mar; 295(5560):1616-7. PubMed ID: 11872804
    [No Abstract]   [Full Text] [Related]  

  • 4. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
    Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
    Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Jitters jeopardize AIDS vaccine trials.
    Cohen J
    Science; 1993 Nov; 262(5136):980-1. PubMed ID: 8235635
    [No Abstract]   [Full Text] [Related]  

  • 6. Antigen presentation and related immunological aspects of HIV-1 vaccines.
    Steinman RM; Germain RN
    AIDS; 1998; 12 Suppl A():S97-112. PubMed ID: 9632991
    [No Abstract]   [Full Text] [Related]  

  • 7. IAVI creates antibody scientist team.
    Birmingham K
    Nat Med; 2002 Aug; 8(8):768-9. PubMed ID: 12152016
    [No Abstract]   [Full Text] [Related]  

  • 8. AIDS vaccines: back to 'plan A'.
    Check E
    Nature; 2003 Jun; 423(6943):912-4. PubMed ID: 12827164
    [No Abstract]   [Full Text] [Related]  

  • 9. [Development of an AIDS vaccine: status report].
    Girard MP
    Med Trop (Mars); 2007 Aug; 67(4):340-6. PubMed ID: 17926791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nucleic acid vaccines for study in AIDS patients are approved. Vaccines of genetic molecules--humoral and cellular immune response].
    Hobom B
    Fortschr Med; 1995 Dec; 113(35-36):12. PubMed ID: 8582688
    [No Abstract]   [Full Text] [Related]  

  • 11. Is an effective HIV vaccine feasible?
    Cohen J
    Science; 2005 Jul; 309(5731):99. PubMed ID: 15994545
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of prophylactic AIDS vaccines: the current state of affairs.
    Hanke T
    Curr Opin Mol Ther; 2003 Feb; 5(1):25-32. PubMed ID: 12669467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [How far away is the first anti-HIV vaccine?].
    Bürk RR
    Fortschr Med; 1994 Mar; 112(7):61-2. PubMed ID: 8175095
    [No Abstract]   [Full Text] [Related]  

  • 14. AIDS vaccine.
    Minn Med; 1991 Mar; 74(3):46. PubMed ID: 2030681
    [No Abstract]   [Full Text] [Related]  

  • 15. An HIV vaccine: breaking the paradigms.
    Fauci AS
    Proc Assoc Am Physicians; 1996 Jan; 108(1):6-13. PubMed ID: 8834058
    [No Abstract]   [Full Text] [Related]  

  • 16. Urgently needed: a filter for the HIV-1 vaccine pipeline.
    Moore JP; Burton DR
    Nat Med; 2004 Aug; 10(8):769-71. PubMed ID: 15286768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying barriers to participation in prophylactic HIV-1 vaccine trials.
    Peters BS
    Int J STD AIDS; 2006 Feb; 17(2):73. PubMed ID: 16464264
    [No Abstract]   [Full Text] [Related]  

  • 18. AIDS research. Debate begins over new vaccine trials.
    Cohen J
    Science; 2001 Sep; 293(5537):1973. PubMed ID: 11557856
    [No Abstract]   [Full Text] [Related]  

  • 19. [AIDS vaccine: who should be selected for the test?].
    Marcus U
    Fortschr Med; 1995 Nov; 113(32):16-7. PubMed ID: 8543269
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunology in AIDS in 1990.
    Sela M
    AIDS; 1990; 4 Suppl 1():S9-14. PubMed ID: 1983804
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.